{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:30:54Z","timestamp":1794562254734,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jpet.2026.104984","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:51:32Z","timestamp":1783781492000},"page":"104984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety, pharmacodynamics, and pharmacokinetics of oral cannabigerol in healthy adults"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6321-7333","authenticated-orcid":false,"given":"David","family":"Wolinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhathri","family":"Srungaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0198-4788","authenticated-orcid":false,"given":"Catherine F.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6765-0671","authenticated-orcid":false,"given":"Zachary J.","family":"Pierce-Messick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6426-8984","authenticated-orcid":false,"given":"C. Austin","family":"Zamarripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2859-116X","authenticated-orcid":false,"given":"Tory R.","family":"Spindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8095-612X","authenticated-orcid":false,"given":"Cristina","family":"Sempio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6413-4820","authenticated-orcid":false,"given":"Jost","family":"Klawitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Campos Palomino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7297-147X","authenticated-orcid":false,"given":"Uwe","family":"Christians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Feldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Vandrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5088-5386","authenticated-orcid":false,"given":"Marcel O.","family":"Bonn-Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8234-0919","authenticated-orcid":false,"given":"Elise M.","family":"Weerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia L.","family":"Bergeria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2026.104984_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/npp.2017.198","article-title":"US epidemiology of cannabis use and associated problems","volume":"43","author":"Hasin","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpet.2026.104984_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103716","article-title":"Trends in the use of cannabis products in Canada and the USA, 2018\u20132020: Findings from the International Cannabis Policy Study","volume":"105","author":"Hammond","year":"2022","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jpet.2026.104984_bib3","author":"Abernethy"},{"issue":"20","key":"10.1016\/j.jpet.2026.104984_bib4","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1001\/jama.2022.20620","article-title":"Closing the Loophole on Hemp-Derived Cannabis Products: A Public Health Priority","volume":"328","author":"Harlow","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jpet.2026.104984_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267498","article-title":"The phytochemical diversity of commercial Cannabis in the United States","volume":"17","author":"Smith","year":"2022","journal-title":"PLOS One"},{"issue":"2","key":"10.1016\/j.jpet.2026.104984_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/jpet.120.000340","article-title":"The pharmacological case for cannabigerol","volume":"376","author":"Nachnani","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"issue":"22","key":"10.1016\/j.jpet.2026.104984_bib7","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.3390\/molecules29225471","article-title":"Cannabigerol (CBG): a comprehensive review of its molecular mechanisms and therapeutic potential","volume":"29","author":"Li","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2026.104984_bib8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fphar.2018.00632","article-title":"Cannabigerol action at cannabinoid CB(1) and CB(2) receptors and at CB(1)-CB(2) heteroreceptor complexes","volume":"9","author":"Navarro","year":"2018","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104984_bib9","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1089\/can.2021.0058","article-title":"Survey of patients employing cannabigerol-predominant cannabis preparations: perceived medical effects, adverse events, and withdrawal symptoms","volume":"7","author":"Russo","year":"2022","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jpet.2026.104984_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1183019","article-title":"Cannabigerol modulates alpha(2)-adrenoceptor and 5-HT(1A) receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat","volume":"14","author":"Mendiguren","year":"2023","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104984_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66879-0","article-title":"Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial","volume":"14","author":"Cuttler","year":"2024","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.jpet.2026.104984_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4841","article-title":"Acute effects of smoked and vaporized cannabis in healthy adults who infrequently use cannabis: a crossover trial","volume":"1","author":"Spindle","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.jpet.2026.104984_bib13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/02698811211021583","article-title":"Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis","volume":"35","author":"Spindle","year":"2021","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jpet.2026.104984_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107969","article-title":"Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis","volume":"211","author":"Schlienz","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2026.104984_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107937","article-title":"Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users","volume":"211","author":"Spindle","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.jpet.2026.104984_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jat\/bkx012","article-title":"Pharmacokinetic profile of oral cannabis in humans: blood and oral fluid disposition and relation to pharmacodynamic outcomes","volume":"41","author":"Vandrey","year":"2017","journal-title":"J Anal Toxicol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104984_bib37","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1089\/can.2023.0174","article-title":"Impact of dietary fat and Oral delivery system on Cannabigerol pharmacokinetics in adults","volume":"9","author":"Story","year":"2024","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jpet.2026.104984_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.drugalcdep.2015.03.019","article-title":"Non-smoker exposure to secondhand cannabis smoke II: effect of room ventilation on the physiological, subjective, and behavioral\/cognitive effects","volume":"151","author":"Herrmann","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.jpet.2026.104984_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12968","article-title":"Sex differences in the acute effects of oral and vaporized cannabis among healthy adults","volume":"26","author":"Sholler","year":"2021","journal-title":"Addict Biol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104984_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/arclin\/11.4.339","article-title":"The Digit Vigilance Test: reliability, validity, and sensitivity to diazepam","volume":"11","author":"Kelland","year":"1996","journal-title":"Arch Clin Neuropsychol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104984_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2340\/16501977-1945","article-title":"Development of a computerized Digit Vigilance Test and validation in patients with stroke","volume":"47","author":"Yang","year":"2015","journal-title":"J Rehabil Med"},{"issue":"2","key":"10.1016\/j.jpet.2026.104984_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1037\/a0036295","article-title":"Response inhibition and psychopathology: a meta-analysis of go\/no-go task performance","volume":"123","author":"Wright","year":"2014","journal-title":"J Abnorm Psychol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104984_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jat\/bkab030","article-title":"Simultaneous quantification of 17 cannabinoids by LC\u2013MS-MS in human plasma","volume":"46","author":"Sempio","year":"2022","journal-title":"J Anal Toxicol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104984_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jat\/bkae048","article-title":"LC-MS-MS quantification of \u03948-THC, \u03949-THC, THCV isomers and their main metabolites in human plasma","volume":"48","author":"Sempio","year":"2024","journal-title":"J Anal Toxicol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104984_bib24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/nu15010178","article-title":"Low-dose administration of cannabigerol attenuates inflammation and fibrosis associated with methionine\/choline deficient diet-induced NASH model via modulation of cannabinoid receptor","volume":"15","author":"Aljobaily","year":"2022","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.jpet.2026.104984_bib25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/joim.13627","article-title":"Cannabidiol-associated hepatotoxicity: a systematic review and meta-analysis","volume":"293","author":"Lo","year":"2023","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.jpet.2026.104984_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1476-5381.2009.00515.x","article-title":"Evidence that the plant cannabinoid cannabigerol is a highly potent \u03b12-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist","volume":"159","author":"Cascio","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpet.2026.104984_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.871962","article-title":"Acute cannabigerol administration lowers blood pressure in mice","volume":"13","author":"Vernail","year":"2022","journal-title":"Front Physiol"},{"issue":"S1","key":"10.1016\/j.jpet.2026.104984_bib28","doi-asserted-by":"crossref","DOI":"10.1152\/physiol.2023.38.S1.5726031","article-title":"Chronic cannabigerol administration lowers blood pressure in phenotypically normal mice","volume":"38","author":"Vernail","year":"2023","journal-title":"Physiology"},{"issue":"1","key":"10.1016\/j.jpet.2026.104984_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/1516-4446-2017-0015","article-title":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test","volume":"41","author":"Linares","year":"2019","journal-title":"Braz J Psychiatry"},{"issue":"19\u201320","key":"10.1016\/j.jpet.2026.104984_bib30","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1007\/s00213-016-4397-4","article-title":"Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats","volume":"233","author":"Brierley","year":"2016","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jpet.2026.104984_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/FBP.0000000000000285","article-title":"A cannabigerol-rich Cannabis sativa extract, devoid of \u03949-tetrahydrocannabinol, elicits hyperphagia in rats","volume":"28","author":"Brierley","year":"2017","journal-title":"Behav Pharmacol"},{"issue":"6830","key":"10.1016\/j.jpet.2026.104984_bib32","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptin-regulated endocannabinoids are involved in maintaining food intake","volume":"410","author":"Di Marzo","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jpet.2026.104984_bib33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/sj.bjp.0705968","article-title":"The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin","volume":"143","author":"Tucci","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104984_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bjp.0706157","article-title":"CB1 cannabinoid receptor-mediated modulation of food intake in mice","volume":"145","author":"Wiley","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"18","key":"10.1016\/j.jpet.2026.104984_bib35","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.3390\/molecules26185601","article-title":"Novel CBG derivatives can reduce inflammation, pain and obesity","volume":"26","author":"Kogan","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.jpet.2026.104984_bib36","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1089\/can.2024.0187","volume":"10","author":"Elder","year":"2025","journal-title":"Cannabis Cannabinoid Res"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:17:49Z","timestamp":1794561469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526011845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022356526011845"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104984","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, pharmacodynamics, and pharmacokinetics of oral cannabigerol in healthy adults","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104984"}}